Drug recall · March 20, 2024
Tobramycin for Injection recall
Why: Failed Stability Specification: Water determination was found not complying with specification.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.
- Lots / codes
Lot #s: 3TB23001, 3TB23002, Exp. 04/30/2025.
- Quantity
- 1160 VIALS
- Company
- Eugia US LLC, East Windsor, NJ
- Distribution
- Nationwide
- Initiated
- February 22, 2024 · Voluntary: Firm initiated
- Classified
- March 14, 2024
- Reported
- March 20, 2024
- Ended
- December 22, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tobramycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.